Testers, L.

diabetes type 2 diabetes allele patient igf-i 192- bp allele subject study marker type 1 diabetes chromosome disease region infarction population level 192- body height polymorphism linkage parkinsonism analysis serum rotterdam genet haplotype recessive growth igf-i levels height early-onset parkinsonism table family mapping control early-onset sample genotype frequency center rotterdam trend 0 1 2 insulin-like promoter locus association factor autosomal mutation research individual igf-i promoter polymorphism rotterdam study control subjects population-based sample homozygosity mapping noncarrier genome evidence genetic parkinson homozygosity todd ja igf-i gene serum igf-i concentration 900 subjects hla-dr population-based dr 4 allele cholesterol report participant glucose parkin screen susceptibility relation park 6 netherland disease haplotype